ArticleMedical oncology (Northwood, London, England)2025

Genetically engineered K562 cells augment NK cell cytotoxicity against acute myeloid leukemia and reduce dependency on IL-15.

Saman Sohrabi Akhkand et al.PubMed ↗Publisher ↗

No numbers read from the abstract.